Featured As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally By Ian YoungDecember 3, 2020
ETF Building Blocks Channel How Increased FDA Activity Can Benefit ETFs in Your Portfolio By Tom LydonNovember 19, 2020
Beyond Basic Beta Channel Bullish on Biotech? The BBH ETF is Not Just a 2020 Play By Ben HernandezNovember 18, 2020
Equity ETF Channel Biotech ETFs Poised for Gains after Moderna Vaccine News By Ian YoungNovember 16, 2020
ETF Building Blocks Channel More than Just COVID: Hot ETFs for Medical Breakthroughs By Tom LydonNovember 5, 2020
Beyond Basic Beta Channel Can’t Get Enough Biotech Exposure in Your Portfolio? By Ben HernandezOctober 29, 2020
ETF Building Blocks Channel Post-Election Considerations for a Nifty Biotech ETF By Tom LydonOctober 7, 2020
ETF Building Blocks Channel A Healthcare ETF Could Benefit From Index Reshuffling By Tom LydonJune 23, 2020